|
Suven Life Sciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
2965.58 Cr.
|
P/BV
|
15.39
|
Book Value (Rs.)
|
8.84
|
|
52 Week High/Low (Rs.)
|
169/83
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 |
| Total Operating Revenues | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 |
| | | | | | |
| Other Income | 21.13 | 8.45 | 5.32 | 7.75 | 14.04 |
| Total Revenue | 32.82 | 21.99 | 17.16 | 21.23 | 28.45 |
| | | | | | |
| EXPENSES | | | | | |
| Employee Benefit Expenses | 18.99 | 18.62 | 21.02 | 18.53 | 17.41 |
| Finance Costs | 0.16 | 0.29 | 0.53 | 0.82 | 0.55 |
| Depreciation And Amortisation Expenses | 6.50 | 6.54 | 4.39 | 4.35 | 4.17 |
| Other Expenses | 120.71 | 120.80 | 113.21 | 75.02 | 112.72 |
| Total Expenses | 146.36 | 146.26 | 139.16 | 98.71 | 134.85 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -113.54 | -124.27 | -122.00 | -77.47 | -106.40 |
| | | | | | |
| Exceptional Items | 7.46 | 6.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | -106.08 | -118.27 | -122.00 | -77.47 | -106.40 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 1.97 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | -5.70 | -14.46 |
| Tax For Earlier Years | -1.00 | 0.00 | 0.00 | 0.38 | 0.31 |
| Total Tax Expenses | -1.00 | 0.00 | 0.00 | -5.32 | -12.18 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -105.08 | -118.27 | -122.00 | -72.15 | -94.22 |
| | | | | | |
| Profit/Loss From Continuing Operations | -105.08 | -118.27 | -122.00 | -72.15 | -94.22 |
| | | | | | |
| Profit/Loss For The Period | -105.08 | -118.27 | -122.00 | -72.15 | -94.22 |
| Consolidated Profit/Loss After MI And Associates | -105.08 | -118.27 | -122.00 | -72.15 | -94.22 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -4.82 | -6.63 | -9.57 | -5.67 | -7.40 |
| Diluted EPS (Rs.) | -4.82 | -6.63 | -9.57 | -5.67 | -7.40 |
